Cost comparison analysis of onasemnogene abeparvovec and nusinersen for treatment of patients with spinal muscular atrophy type 1 in the Netherlands

Simon van der Schans; Rimma Velikanova; Diana Weidlich; Ruth Howells; Anish Patel; Matthias Bischof; Maarten J. Postma; Cornelis Boersma

doi:10.1007/s10198-024-01754-3

Cost comparison analysis of onasemnogene abeparvovec and nusinersen for treatment of patients with spinal muscular atrophy type 1 in the Netherlands

Simon van der Schans, Rimma Velikanova, Diana Weidlich, Ruth Howells, Anish Patel, Matthias Bischof, Maarten J. Postma, Cornelis Boersma

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Number of pages	10
Journal	European Journal of Health Economics
DOIs	https://doi.org/10.1007/s10198-024-01754-3
Publication status	E-pub ahead of print - 21 Feb 2025

Keywords

Cost comparison analysis
Gene therapy
Nusinersen
Onasemnogene abeparvovec
Spinal muscular atrophy
The Netherlands

Access to Document

10.1007/s10198-024-01754-3Licence: CC BY

Cite this

van der Schans, S., Velikanova, R., Weidlich, D., Howells, R., Patel, A., Bischof, M., Postma, M. J., & Boersma, C. (2025). Cost comparison analysis of onasemnogene abeparvovec and nusinersen for treatment of patients with spinal muscular atrophy type 1 in the Netherlands. European Journal of Health Economics. Advance online publication. https://doi.org/10.1007/s10198-024-01754-3

@article{1557373d98f341e5bf111a1ff7561a9a,

title = "Cost comparison analysis of onasemnogene abeparvovec and nusinersen for treatment of patients with spinal muscular atrophy type 1 in the Netherlands",

keywords = "Cost comparison analysis, Gene therapy, Nusinersen, Onasemnogene abeparvovec, Spinal muscular atrophy, The Netherlands",

author = "{van der Schans}, Simon and Rimma Velikanova and Diana Weidlich and Ruth Howells and Anish Patel and Matthias Bischof and Postma, {Maarten J.} and Cornelis Boersma",

year = "2025",

month = feb,

day = "21",

doi = "10.1007/s10198-024-01754-3",

language = "English",

journal = "European Journal of Health Economics",

issn = "1618-7598",

publisher = "Springer Verlag",

}

TY - JOUR

T1 - Cost comparison analysis of onasemnogene abeparvovec and nusinersen for treatment of patients with spinal muscular atrophy type 1 in the Netherlands

AU - van der Schans, Simon

AU - Velikanova, Rimma

AU - Weidlich, Diana

AU - Howells, Ruth

AU - Patel, Anish

AU - Bischof, Matthias

AU - Postma, Maarten J.

AU - Boersma, Cornelis

PY - 2025/2/21

Y1 - 2025/2/21

KW - Cost comparison analysis

KW - Gene therapy

KW - Nusinersen

KW - Onasemnogene abeparvovec

KW - Spinal muscular atrophy

KW - The Netherlands

U2 - 10.1007/s10198-024-01754-3

DO - 10.1007/s10198-024-01754-3

M3 - Article

C2 - 39982664

SN - 1618-7598

JO - European Journal of Health Economics

JF - European Journal of Health Economics

ER -